Showing results (151-160 of 268) with videos related to
Sort By:
Pageof 27
Gynecologic Oncology|January 1, 1993
Estro-progestinic replacement therapy modulates the levels of basic fibroblast growth factor (bFGF) in postmenopausal endometriumM Rusnati, G Casarotti, S Pecorelli, et al.Carcinogenesis|February 1, 1990
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305M Presta, F Legati, R Chiesa, et al.Cell Regulation|September 1, 1991
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cellsM Presta, L Tiberio, M Rusnati, et al.Growth Factors (Chur, Switzerland)|January 1, 1990
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometriumM Rusnati, G Casarotti, S Pecorelli, et al.Chemico-Biological Interactions|June 1, 1984
Optical isomers of the hepatocarcinogenic beta-blocker ZAMI 1305: influence on nucleic acids synthesis and DNA integrityC Mazzocchi, M Presta, S Ziliani, et al.Chemico-Biological Interactions|December 1, 1984
Early liver alterations induced by the sex-dependent hepatocarcinogen beta-blocker ZAMI 1305M Presta, C Mazzocchi, S Ziliani, et al.Toxicologic Pathology|January 1, 1986
Further studies on the tumor-initiating activity of the beta-blocker DL-ZAMI 1305N Pacces, M Braga, T Zavanella, et al.The Journal of Cell Biology|February 1, 1993
Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cellsR Flaumenhaft, M Abe, Y Sato, et al.Kidney International|May 1, 1997
Latent transforming growth factor-beta: structural features and mechanisms of activationJ S Munger, J G Harpel, P E Gleizes, et al.Current Eye Research|March 13, 1999
Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathyR D Higgins, K Yu, R J Sanders, et al.Pageof 27